| |
Newsletters & Publications
| Volume
15 - Number 2 |
Summer 1998 |
COMMON ABBREVIATIONS
BMI: body mass index (kg/m2)
CHD: coronary heart disease
CHO: carbohydrate
CI: confidence interval
CVD: cardiovascular disease
ene: energy
HDL: high density lipoprotein
LDL: low density lipoprotein
Lp(a): lipoprotein (a)
MI: myocardial infarction
MUFA: monounsaturated fatty acids
NCEP: National Cholesterol Education Program
P:S: dietary polyunsaturated:saturated fat ratio
PUFA: polyunsaturated fatty acids
RR: relative risk
SFA: saturated fatty acids
TAG: triacylglycerol
VLDL: very low density lipoprotein
The majority of previous efficacy studies on
CHD risk reduction with reduced fat intake have been conducted
with white middle-aged men, and accordingly the plasma lipid responses
to dietary fat changes for women, nonwhites, and older people are
limited. The DELTA study was designed to investigate the effects
of a reduced saturated fat diet on plasma lipoprotein levels in
these sub-populations. In this multi-center, double-blind crossover
trial, 103 healthy adults between the ages of 22-67 years old were
fed three isocaloric test diets with varying total and saturated
fat contents. The average American diet (AAD) consisted of 15%
energy as saturated fat and 34.3% energy as total fat; the Step
1 diet consisted of 9% energy in saturated fat and 28.6% energy
in total fat; and the low saturated fatty acid diet (Low-Sat) consisted
of 6.1% energy from saturated fat and 25.3% energy from total fat.
Subjects consumed each test diet for 8 weeks, followed by a 4-6
week washout period. Dietary cholesterol (300 mg/day), percent
calories from protein (15%), and trans fatty acid content (<1.5%
energy) remained constant in all three study diets. All meals,
except Saturday dinner, were prepared by the research centers.
Subjects ate 2 meals at the centers and a third meal and a snack
were consumed offsite. Prepacked meals were consumed on weekends.
Tray checks and dietary reports were used to assess compliance.
The study cohort was 55% female and 45% males, of which, 35% were
black females and 20% black males. Also, 32% were postmenopausal
women and 35% were males over 40 years old.
Data from all 4 research sites, Columbia University,
Pennington Biomedical Research Center, Pennsylvania State University,
and University of Minnesota were similar. Researchers attributed
this to the "virtually identical diet" eaten at each
study site.
Results from this study confirmed several common
theories regarding the effect of dietary fat on metabolism. For
example, as percent of calories from saturated fat and total fat
decreased, plasma total cholesterol, LDL, HDL, apo B, and apo A
levels decreased, while plasma TAG and cholesterol:HDL ratio increased.
The table below presents the percent change in plasma lipid and
apolipoprotein levels as volunteers decreased their saturated fat
intake from 15% to 6%. When the data were analyzed separately for
subjectsÕ sex, race, age (men only), and menopausal status,
the effects of the three diets on plasma lipid and lipoprotein
levels were similar to results obtained as a whole. For example,
the mean decrease in total cholesterol with the Step 1 diet compared
to the AAD diet was 5.5% in subgroup analyses and 5.5% in the original
analysis. Similar results were seen for plasma LDL cholesterol
levels in both analyses. Also, even though each subgroup had different
baseline plasma lipid and lipoprotein levels, the percent change
was similar between groups. Plasma total cholesterol and LDL cholesterol
decreased 5.2% and 6.3%, respectively in postmenopausal women on
the Step 1 diet, while it decreased 5.6% and 7.4% in pre-menopausal
women on the Step 1 diet. In Blacks, the plasma total cholesterol
fell by 5.4% on the Step 1 diet and 4.2% on the Low-Sat diet, while
in nonblacks, the total cholesterol fell by 5.5% and 3.5% with
the Step 1 and the Low-Sat diet, respectively. In men, LDL cholesterol
decreased by 9.3 mg/dl and 4.9 mg/dl on the Step 1 and the Low-Sat
diet, respectively. In women, LDL cholesterol decreased by 9.1
mg/dl and 5.5 mg/dl on the Step 1 and the Low-Sat diet.
Researchers were surprised by the increase in
plasma Lp(a) concentration on the Step 1 and Low-Sat diets since
variability in plasma Lp(a) was thought to be determined by genetics
rather than diet. Therefore, the increased negative lipid profile
(increase in Lp(a) and TAG and decrease in HDL levels on the Step
1 and Low-Sat diet) seen in this study raises questions regarding
the efficacy of these diets in lowering CHD risk. Lastly, the cholesterol
lowering effects were much lower than the predicted equations of
Keys et al. and Hagstead et al. Ginsberg and colleagues proposed
that this might have been due to the fact that 22% of SFA was stearic
acid and thus did not effect plasma lipid levels.
| Plasma Levels |
% Change AAD to Step 1 |
% Change Step 1 to Low-Sat |
| TC |
-5.49* |
-3.98* |
| LDL |
-7.00* |
-4.34* |
| HDL |
-7.09* |
-4.74* |
| TAG |
+8.58* |
+0.65* |
| Apo B |
-2.74 |
-1.76 |
| Apo A-I |
-4.78* |
-3.69* |
| Lp(a) |
+9.68* |
+7.06* |
| TC:HDL |
+2.21 |
+1.20 |
*P<0.01
KEY Messages
- Plasma Lp(a), TAG, and TC:HDL ratio increased on the Step 1
diet and Low-Sat diet.
- Plasma total cholesterol, LDL, apo B, HDL, and apo A decreased
on the Step 1 and Low-Sat diet.
- Race, sex, age (men only), and postmenopausal status did not
affect the changes in plasma lipoprotein levels.
Editor's Comment:
The DELTA Study provides a number of interesting observations on
the effectiveness of the Step 1 diet in lowering plasma lipids
and lipoproteins, as well as raising a number of questions regarding
the effects of this dietary pattern on CHD risk. The observed decrease
in plasma cholesterol levels with initiation of the Step 1 diet
in this well controlled trial was 5% (11 mg/dl) compared to the
average American diet (AAD), and the percent decreases in LDL and
HDL cholesterol levels were comparable. With further restrictions
in saturated fat to 6% of calories, the study subjects lowered
their plasma cholesterol levels an additional 4%, and again the
percent decreases were virtually equal for plasma LDL and HDL cholesterol
levels. The data indicate that these fat restricted diets had no
effect on the plasma LDL:HDL ratio. The unanswered question from
this study is whether the dietary interventions actually lower
CHD risk given the studies indicating that the LDL:HDL ratio is
a significant determinant of CHD relative risk.
What is surprising is the observation that with decreasing saturated
fat calories, plasma levels of Lp(a) increased. What this mean
in terms of thrombotic risk is clearly not known, but other studies
suggest that it probably is not beneficial. The observation that
plasma Lp(a) concentrations are altered by diet was unanticipated,
and that Lp(a) increases with decreasing fat calories is certainly
a topic for further research. It should also be remembered that
decreasing fat calories causes some subjects to have small, dense
LDL particles and the DELTA Study had similar results in that plasma
LDL cholesterol levels decreased to a greater extent than plasma
apo B levels. One conclusion from the DELTA Study is that diet-mediated
changes in plasma total cholesterol do not always provide an appropriate
end-point for determining CHD risk reduction by the intervention.
The question now becomes how to relate the benefits of LDL cholesterol
lowering versus the unknown effects of plasma HDL cholesterol lowering,
the increase in plasma Lp(a), and production of small, dense LDL
particles? |
Ginsberg, H.N., Kris-Etherton, P., Dennis, B.,
et al. Effects of reducing dietary saturated fatty acids on plasma
lipids and lipoproteins in healthy subjects. The Delta Study, Protocol
1. Arterioscler Thromb Vasc Biol 1998;18:441-449.
Table of Contents
Studies by Hsieh et al. investigated the health
benefits associated with physical activity in 3,331 middle-aged
Japanest employees or office workers who were undergoing a routine
health exam ate men. The majority of subjects were either government
employees or office workers who were undergoing a routine health
exam at the time of the study enrollment. Subjects were classified
into sedentary, active 1 day/week, active 2 days/week, or active > 3
days/week study groups based on their response to a physical activity
survey questionnaire. Also, each subject's blood pressure, lipids,
glucose levels, obesity, and smoking status were measured at the
onset of the study. Upon examination of the data, researchers learned
that the largest number (2,400) of study cohorts were in the sedentary
group while only 204 men exercised 3 or more times per week.
The only similarity among the different study
groups was their mean age of 48 years. All the other CHD risk factors
were much higher in the sedentary men relative to the active groups.
For example, people who exercised >1 day were more likely
to have higher HDL levels and lower plasma total cholesterol, TAG,
blood pressure, and fasting blood glucose levels than the sedentary
group. Also, "the sum of the risk factor scores for hypertension,
abnormal glucose tolerance, hypertriglyceridemia, hypercholesterolemia,
and low HDL level (one point for each if present) was highest in
the sedentary group (1.38, 1.19, 1.19, 0.99 for the sedentary group
and the groups who exercised 1, 2, and > 3 days per week)." Men
who exercised > 2 days/week had lower waist-to-height
ratios, subcutaneous fat around the umbilicus, and prevalence of
fatty liver. Lastly, incidence of smoking decreased with increased
activity level as well as increased HDL levels in these groups.
Like previous studies, this study corroborates the fact that physical
activity is a positive independent factor for an increased HDL
cholesterol level. Hsieh and colleagues concluded that any amount
of physical activity is better than no activity, however, in order
to reap the maximum health benefit, it is better to exercise for
at least 30 minutes more than 3 days a week as recommended by the
American College of Sports Medicine.
Hsieh, S.D., Yoshinaga, H., Muto, T., et al. Regular
physical activity and coronary risk factors in Japanese men. Circulation 1998;97:661-665.
Table of Contents
High carbohydrate, low-fat diets have been recommended
for endurance athletes to enhance glycogen stodiets might not be
in their best interest, but rather that a high fat dirage. Now,
new studies are suggesting that maybe these diets might not be
in their best interest, but rather that a high fat diet could be
more appropriate. In this clinical study, Leddy et al. investigated
the effects of varying dietary fat intake on CHD risk factors in
runners. Twenty five runners (12 men and 13 women) in Buffalo,
NY were enrolled in the study. All subjects trained at least 35
miles per week and were not taking any lipid altering medication.
Subjects were instructed to follow 3 test diets consisting of 16%,
30%, and 42% calories from fat for 4 week increments. However,
due to their fat phobia, 13 subjects (6 men and 7 women) were noncompliant
with the 42% fat diet. Therefore, the investigators used only 12
sets of data when analyzing CHD risk with the high fat diet. Physiological
and blood lipid parameters were measured after each diet. Analysis
of subjects' dietary logs indicated that, on average, subjects
did actually consume 16%, 30%, and 42% of calories from fat as
prescribed. Also, as the percent of calories from fat increased,
total calories consumed per day increased while the percent of
calories from carbohydrate decreased. During the 42% fat diet,
volunteers consumed 20% more calories than on the 16% fat diet.
The polyunsaturated to saturated fat ratio decreased with increasing
fat in the diet; 0.70 for the 16% fat diet, 0.50 with the 30% fat
diet, and 0.49 on the 42% fat diet. Dietary cholesterol intake
also increased as the percent of calories from fat increased indicating
that subjects were consuming more animal products.
In spite of the 20% increase in total calories
on the high fat diet, no negative physiological changes was observed
in these athletes. Most lipoprotein parameters, except HDL cholesterol
and apo A1, did not change significantly as subjects increased
fat intake from 16% to 42%. However, plasma HDL cholesterol and
apo A1 levels were highest on the 42% fat diet and lowest on the
16% fat diet. For example, HDL cholesterol level increased from
50 mg/dl to 69 mg/dl between 16% fat and 42% fat diet. Lastly,
the TC/HDL levels were highest with the 16% fat diet and lowest
with the 42% fat diet. Even though conventional wisdom holds that
a high fat diet can have an adverse effect on CHD risk, these findings
show that in endurance athletes, a high fat diet is more appropriate
in reducing their CHD risk. Low-fat diet resulted in negating the
benefit achieved by exercising by increasing plasma TAG and decreasing
HDL cholesterol and apo A1 levels. In conclusion, this study shows
that a diet consisting of 42% calories from fat did not increase
the CHD risk factors in trained men and women.
Leddy, J., Horvath, P., Rowland, J., et al. Effect
of a high or a low fat diet on cardiovascular risk factors in male
and female runners. Med. Sci. Sports Exerc 1997;29:17-25.
Table of Contents
Recently, the link between hyperhomocysteinemia
and CVD has received much media attention; however, this is not
a new discovery. This relationship was initially identified in
1969 by McCully in two children with an inborn metabolic disorder.
But since than, many studies have shown a direct relationship between
an elevated plasma homocysteine and CHD risk, and an inverse relationship
between plasma folate and vitamin B6 concentrations
and homocysteine levels. Results from the Nurses' Health Study
and the European Concerted Action Project have confirmed and added
new information to this research area.
In the Nurses' Health Study, researchers compared
the folate and vitamin B6 intakes of 80,082 women with
the incidence of nonfatal MI (n=658) and fatal CHD (n=281) during
a 14 year follow-up period. Biennial semiquantitative food frequency
questionnaires were used to collect the dietary data. The food
frequency data showed that the major sources of folate and vitamin
B6 were multivitamins followed by cold cereals, orange
juice, lettuce, and eggs for folate and beef, cold cereals, and
potatoes for vitamin B6. Rimm and colleagues reported
that the multivariate RR for CHD was 0.69 (95% CI, 0.55-0.87) for
women in the highest quintile for folate compared to the lowest
quintile. The mean folate levels in each quintile were 158 µg/d,
217 µg/d, 276 µg/d, 393 µg/d, and 696 µg/d,
respectively. The multivariate RR for CHD was 0.67 (96% CI, 0.53-0.85)
for women in the highest vitamin B6 group. The mean
dietary B6 level in each quintile was 1.1 mg/d, 1.3
mg/d, 1.7 mg/d, 2.7 mg/d, and 4.6 mg/d. The data indicated that
each increase of 200 µg of folate and 2 mg of vitamin B6 was
associated with a RR of 0.89 and 0.83, respectively. Unlike folate,
in the case of vitamin B6, vitamin source, i.e. food
or supplements, did impact the inverse relationship. Vitamin B6 supplements
apparently decreased CHD risk more than dietary vitamin B6.
Smoking and vitamin E intake were 2 major confounding
factors that attenuated the association between CHD and folate
and vitamin B6 intake. The independent effects of folate
and vitamin B6 on CHD risk were difficult to isolate
in this study, since multivitamins and breakfast cereals contained
both vitamins. Lastly, the RR between extreme quintiles of folate
intakes were different across levels of alcohol intake, smoking
status, and family history of CHD, but not with vitamin B6.
Nurses in the highest folate intake group with more than 1 alcoholic
drink per day had the lowest RR for CHD (0.27).
Robinson et al. conducted a multi-center, case-control
study to test the interrelationship between homocysteine, B vitamins,
and vascular disease. This study took place in 19 different centers
in 9 European countries with 750 cases and 800 control subjects.
Control groups were geographically matched with case subjects.
The test subjects were recently diagnosed with vascular disease
prior to being enrolled in the study. Primary measurements for
this study included plasma homocysteine, red cell folate, B12,
B6, and lipoprotein index. For the purpose of this study,
deficiency of folate, B12, and B6 were set
at concentration levels of <372 nmol/l, <125 pmol/l, and <20
nmol/l, respectively and low levels were defined as concentrations
of 513 nmol/l for folate, 139.5 pmol/l for B12, and
23.3 nmol/l for B6. The incidences of vitamin B6,
B12, and folate deficiency were much higher in the case
group. Four percent of case subjects were deficient in folate versus
2% in the control group and 35% of cases had low B6 levels
versus 20% the in control group.
As predicted, researchers observed higher fasting
and post load homocysteine values in case subjects than control
subjects regardless of gender. The increase in homocysteine levels
with a methionine-loading test was much greater in female subjects
than male subjects. The difference in folate concentrations between
case and control groups was only evident in males. For example,
in men red cell folate values were 819 nmol/l and 876 nmol/l in
cases and controls but in women, it was 727 nmol/l and 726 nmol/l
in cases and controls. Case status did not effect B12 concentrations,
however, B6 levels were higher in case subjects than
control subjects. The investigators reported a negative correlation
between plasma homocysteine and all three vitamins, but only low
levels of folate and vitamin B6 were associated with
vascular disease. The RR for vascular disease was 1.50 with folate
levels below 513 nmol/l and 1.84 for vitamin B6 levels
below 23.3 nmol/l.
Results from the two studies corroborate previous
findings regarding the relationship between low folate and B6 and
CHD risk due to increased plasma homocysteine levels. But the data
from the Nurses' Health Study suggest that current RDA for vitamin
B6 and folate is adequate for preventing deficiency,
however, it might not be sufficient to protect people from CHD
risk.
Rimm. E.B., Willett, W.C., Hu, F.B., et al. Folate
and vitamin B6 from diet and supplements in relation
to risk of coronary heart disease among women. JAMA 1998;279-359-364.
Robinson, K., Arheart, K., Refsum, H., et al.
Low circulating folate and vitamin B6 concentration
Risk factors for stroke, Peripheral vascular disease, and coronary
artery disease. Circulation 1998;97:437-443.
Table of Contents
This January 1, 1998, the Food and Drug Administration
has required all cereal-grain products to be fortified with folic
acid. This initiative was introduced to increase folic acid intake
by women of childbearing age and thus decrease the incidence of
congenital neural-tube defect in infants. One side benefit of fortification
of folic acid in the food supply is the potential decrease in CHD
risk resulting from lowered plasma homocysteine levels. It has
even been predicted that 19,000 lives per year could be saved from
vascular disease with increased folate intake.
Using 75 older volunteers (> 45 years
old) with history of CHD, Malinow and colleagues conducted a double-blind,
placebo-controlled, crossover trial to test this theory. The three
test diets, A, B, and C, contained 127 µg, 499 µg, and
655 µg of folic acid, respectively, in 30 grams of breakfast
cereal consumed each morning. The diets also provided 100% RDA
for vitamins C, E, B1, B2, B3,
B5, B6, B12, iron, and zinc; 25%
RDA of vitamin A; and 10% RDA of vitamin D. The placebo diet contained
the same amounts of all vitamins and minerals except folate, B6,
and B12. Only the naturally occurring amounts of folate
(10 µg), B6 (0.11 µg), and B12 (0.13 µg)
were in the placebo diet. The subjects consumed either one of the
test diets or a placebo diet for the first 5 weeks followed by
a 5 week washout period than 5 more weeks on the crossover diet.
According to the baseline data, subjects in all
3 test groups had similar CHD risk factors, as well as similar
plasma homocysteine and folic acid levels. But, following the test
diets, plasma homocysteine levels in group A decreased by 3.7%,
group B by 11.0%, and group C by 14%, while the plasma folic acid
levels increased by 30.8%, 64.8%, and 105.7% with study diets A,
B, and C, respectively. However, the changes in these levels were
only significant in test groups B and C. Therefore, results from
Malinow's study, show that when it comes to reducing CHD, risk
due to elevated plasma homocysteine levels, the current level of
folic acid fortification (140 µg per 100 gm of cereal product)
seen in group A was insufficient. Thus, in order to achieve significant
CHD risk reduction benefit, folic acid fortification should be
increased by 4 to 5 times current level.
Boushey, C.J., Beresford, S.A., Omenn, G.S., et
al. A quantitative assessment of plasma homocysteine as a risk
factor for vascular disease: probable benefits of increasing folic
acid intakes. JAMA 1995;274:1049-1057.
Malinow, M.R., Duell, P.B., Hess, D.L, et al.
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified
with folic acid in patients with coronary heart disease. N
Engl J Med 1998;338:1009-1015.
Table of Contents
Using data from the Physicians' Health Study,
Albert and coworkers investigated the relationath. In this prospective
cohort study, 20,551 healthy, male physicians betwship between
fish consumption and risk of cardiac death. In this prospective
cohort study, 20,551 healthy, male physicians between 40 to 84
years old were enrolled and followed for 11 years. Subjects' health
status and risk factors for CVD were recorded at onset of the study
in 1982. Subjects' dietary patterns were measured between 12 and
18 months of the study with a semiquantita-tive food frequency
questionnaire. Also, after the first year, cardiovascular events
were measured annually with a follow-up questionnaire. The reported
deaths were confirmed by examining medical records and in cases
of insufficient data, family members were interviewed for further
information.
For the purpose of this study, types of fish consumed
by volunteers were classified into 4 categories: canned tuna, dark
fish, other fishes, and shellfish. The marine sources of omega-3
fatty acids consumed were calculated by multiplying the frequency
of the 4 fish categories with different omega-3 fatty acid factors
for these fish. The omega-3 fatty acid factors for canned tuna,
dark fish, other fishes, and shellfish were 0.69 gm, 1.37 gm, 0.17
gm, and 0.46 gm, respectively. Fish intake in this study population
ranged from rarely or never to 2 or more per day.
According to the returned question-naires, 80%
of subjects ate fish between 1 to 4 times per week, 3.1 % rarely
or never ate fish, and 10.8% ate fish more than 5 time per week.
Researchers also found that people in the highest fish consumption
group were physically more active, smoked less, drank more alcoholic
beverages, took more vitamin supplement, and had higher plasma
cholesterol levels and blood pressure than people with the lowest
fish consumption. These confounding CVD risk factors were taken
into account in the analysis.
During the follow-up period, 133 sudden deaths
and 737 MI were reported. While the sudden cardiac deaths had an
inverse relationship with fish intake, no such relationship was
observed for MI cases. For example, the relative risk of sudden
death for subjects with 1-3 fish intake per month and >1
fish meals per week were 0.64 ( 95% CI, 0.26-1.58) and 0.48 (95%
CI, 0.24-0.96), respectively. The relative risk for MI with 1-3
fish consumption per month and >1 fish consumption per
week were 0.91 ( 95% CI, 0.55-1.53) and 0.99 (95% CI, 0.64-1.54),
respectively. The relative risks for the 4 quartiles of omega-3
fatty acid intake were 0.58, 0.34, 0.60, and 0.43, respectively.
In the case of MI, non-sudden cardiac death, CHD death, and CVD
mortality, fish intake of >1 per month did not affect
risk. However, fish intake of 1 per week was associated with a
significant reduction in total mortality.
This study contradicts the Western Electric Study
findings, which showed no relationship between sudden cardiac death
and fish intake but a significant inverse relationship in CHD death
and non-sudden cardiac death. The investigators speculated that
this contradicting finding was due to different definitions for
sudden death. In the Physicians' Health Study, sudden death occurred
within one hour while it meant less than 12 hours in the Western
Electric Study.
Albert, C.M., Hennekens, C.H., O'Donnell C.J.,
et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-28.
Table of Contents
Until now, without scientific evidence, peopty
of television viewing for the increased obesity in the Unile have
blamed excessive consumption of fast food and the inactivity of
television viewing for the increased obesity in the United States.
But, thanks to a new study by Jeffery and French, we now have scientific
data to support the correlation between increased fast food intake
and watching television with obesity. In this cross-sectional and
longitudinal study, researchers analyzed the association between
fast food consumption and television viewing with change in BMI
of 1,059 volunteers (198 men and 861 women) between 20-45 years
of age. According to the baseline data, a high number of fast food
meals consumed were positively associated with increased total
calories and calories from fat in all study groups. However, this
relationship was seen only in women volunteers with television
viewing. Television viewing and fast food eating were also significantly
associated with changes in women's BMI but not significant in changes
in men's BMI. This relationship was strongest in low-income women.
Television viewing was the most important factor in predicting
weight gain in high-income women. The lack of association found
between fast food intake and television viewing and BMI in men
did contradict the study hypothesis, but researchers speculated
that it might have been due to the fact that subjects in this study
were volunteers for a weight gain prevention study. In conclusion,
this study does suggest that abundance of fast food and excessive
television viewing can contribute to the increase obesity in the
U.S.
Jeffery, R.W., French, S.A., Epidemic obesity
in the United States: Are fast foods and television viewing contributing? Am
J Public Health 1998;88:277-280.
Table of Contents
Previous studies have shown that smoking increases
the risk of heart disease and stroke. However, data on the relationship
betwe with the progression of atherosclerosis were limien active
cigarette smoking and exposure to environmental tobacco smoke (ETS)
with the progression of atherosclerosis were limited. Howard et
al. measured changes in carotid artery intimal-medial thickness
(IMT) in 10,914 people in the Atherosclerosis Risk in Community
(ARIC) Study. In this longitudinal study, baseline IMT and follow-up
IMT at 3 years were measured using a B-mode real-time ultrasound.
Also, physiological and lipoprotein risk factors were measured
at baseline. Based on their smoking status, subjects were divided
into smokers (n=2,956), past smokers without exposure to ETS (n=1,344),
past smokers with exposure to ETS (n=1,849), nonsmokers without
exposure to ETS (n=2,316), and nonsmokers with exposure to ETS
(n=2,449). Researchers adjusted the data for demographic characteristics,
CVD risk factors, and lifestyle variables to account for confounding
CHD risk factors.
The adjusted data showed that nonsmokers without
exposure to ETS had the lowest atherosclerosis progression rate
(25.9 µm) in 3 years and smokers had the highest atherosclerosis
progression rate of 43.0 µm. The mean IMT progression was
31.6 µm for nonsmokers with exposure to ETS, 32.8 µm
for past smokers without exposure to ETS, and 38.8 µm for
past smokers with exposure to ETS. Howard et al. concluded that
continued smoking, past smoking, and exposure to ETS increased
the progression of atherosclerosis by 50%, 24%, and 20%, respectively,
over nonsmokers not exposed to ETS. Also, regardless of different
smoke exposure, people with diabetes had higher progression rates
than non-diabetics with similar smoking exposure. Hypertensives
and people with CHD had slightly higher rates of atherosclerosis
progression than people without these chronic conditions at the
same smoking exposure. Lastly, even though atherosclerosis progression
was 18% higher in current smokers than past smokers, when pack-years
were included in the analysis the higher rate of progression was
no longer significant. The pack-years for current smokers was 31
while for past smokers not exposed to ETS and exposed to ETS were
19 and 24, respectively.
Results from this study show that exposure to
tobacco smoke through either direct smoke or second hand smoke
can increase an individual's CHD risk by increasing IMT of the
carotid artery. The frequency of tobacco smoke exposure and diabetes
are two strongest factors in atherosclerosis progression due to
ETS.
Howard, G., Wagenknecht, L.E., Burke, G.L., et
al. Cigarette smoking and progression of atherosclerosis. The atherosclerosis
risk in communities (ARIC) study. JAMA 1998;279:119-124.
Table of Contents
During the past year I have been fortunate enough
to give lectures on the dietary cholesterol-plasma ch Rica and
Hong Kong. What I have found most startling is the enormous olesterol
issue in a variety of locations including Costa Rica and Hong Kong.
What I have found most startling is the enormous impact that the
dietary recommendations from USA health promotion groups has world
wide. This seems to be especially true when talking about the number
of eggs one is allowed to eat each week. In Costa Rica the medical
community is so concerned about dietary cholesterol that it recommends
the public restrict their consumption to no more than three eggs
per week. And while this is not all that different from some US
recommendations ten years ago, what makes this restriction disturbing
is that in Costa Rica 25% of the population lives in poverty. One
must question the logic of telling many of those already undernourished
that nutrient dense, affordable eggs should be excluded from the
diet. This is clearly an exaggerated view of the relationship between
dietary cholesterol and heart disease risk, as well as an unbalanced
risk-benefit consideration.
In Hong Kong the dietary cholesterol restrictions
are even more pronounced with physicians recommending egg yolk
consumption be limited to no more than two visible eggs per week.
The logic is that, since eggs are used in so many commonly eaten
foods in Hong Kong, the only way to effectively limit dietary cholesterol
is to restrict visible eggs in the diet. The most striking point
here is that Hong Kong, as well as mainland China, is being inundated
with American style fast food chains providing burgers and fries
in place of steamed fish and rice noodles. And the youth of Hong
Kong, like the youth of America, find the fast food chains to be
just too enticing. What really makes all this so interesting is
that in both countries there is very little communicated about
the CHD risks associated with saturated fats in the diet. The primary
emphasis of the public health approaches to reducing heart disease
risk deals largely with reducing the dietary cholesterol intake
of the population. Sounds a lot like the USA about a dozen years
ago when "cholesterol-free" was the magic cliche for
instant market acceptance by health conscience consumers. And what
is the basis for these inept endeavors at public health nutrition?
The egg restricting dietary recommendations from some US health
promotion groups.
And the confusion about dietary cholesterol is
certainly not finished in this country either. One of the most
commonly heard remarks at the Egg Nutrition Center exhibit booth
at the annual meeting of the American Association of Retired Persons
(AARP) was, "my doctor said I couldn't have more than two
eggs a week." It seems that the simplistic message to "cut
out eggs" is still a common prescription being given to many
elderly patients. This makes little sense given the number of studies
showing that dietary cholesterol has little effect on plasma cholesterol
levels, and that eggs are an affordable, convenient and appropriate
source of high quality nutrition. For these populations, such restrictions
would have little or no CHD risk lowering benefit.
So for the poor, the elderly and the fast food
crowd, eggs remain a member of the "bad food group" thanks
in large part to a twenty-five year old cholesterol-phobia promulgated
by USA health promotion groups. Little does it matter that most
countries of the world do not include dietary cholesterol restrictions
in their national dietary guidelines, the fact that America does
goes a long way in convincing physicians around the world that
dietary cholesterol restrictions, and egg limitations, are reasonable
approaches to CHD risk reduction. One wonders how long this futile
path of prevention will be followed before the saturated fat and
total calories message impacts on the world-wide public health
establishment. Until then the only reductions that will be accomplished
will be in the overall nutritional status of subsets of these populations.
Donald J. McNamara, Ph.D.
Executive Editor, Nutrition Close-Up
Table of Contents
Executive
Editor: Donald J. McNamara, Ph.D.
Writer/Editor: Linda Min, M.S., R.D.
Nutrition Close-Up is published quarterly
by the Egg Nutrition Center. Nutrition Close-Up presents
up-to-date reviews, summaries and commentaries on the latest research
investigating the role of nutrition in health promotion and disease
prevention, and the contributions of eggs to a nutritious and healthful
diet. Nutrition and health care professionals can receive a FREE
subscription for the newsletter by contacting the ENC.
Back
to Top
|
|